Zumutor Biologics
Biotechnology - Cambridge, Massachusetts, United States
Zumutor Biologics Employees
Zumutor Biologics Senior Management
Zumutor Biologics Details
At Zumutor, we are on a mission to develop novel novel immuno onco-therapeutics that drive transformational improvements in cancer treatment through NK cell engagement. We leverage our proven proprietary antibody discovery- INABLR™ for fast track Antibody discovery and development. Our team works in collaboration with a world class Scientific Advisory Board with expertise in immuno-oncology and clinical development. Our lead asset (ZM008) is a first-in-class antibody that targets certain receptors that blocks NK cell inhibitory signal and enables NK cell activation to generate a potent immune response. Development is on track for an IND filing by Q2 2022 and Phase 1 clinical trial thereafter. We are headquartered in CIC Cambridge Campus, MA and R&D is carried out at ISO certified lab in Bangalore, India
Zumutor Biologics Technologies
Email Providers
Gmail
CMS
WordPress.org
Tag Management
Google Tag Manager
Other
Google Maps (Non Paid Users)